These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
508 related articles for article (PubMed ID: 26203687)
1. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy. Song S; Mao G; Du J; Zhu X Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687 [TBL] [Abstract][Full Text] [Related]
2. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691 [TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462 [TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy. Chen Z; Lai X; Song S; Zhu X; Zhu J Drug Deliv; 2016 May; 23(4):1369-73. PubMed ID: 26017099 [TBL] [Abstract][Full Text] [Related]
5. Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy. Zhang J; Xiao X; Zhu J; Gao Z; Lai X; Zhu X; Mao G Int J Nanomedicine; 2018; 13():3039-3051. PubMed ID: 29861635 [TBL] [Abstract][Full Text] [Related]
6. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy. Lin M; Teng L; Wang Y; Zhang J; Sun X Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688 [TBL] [Abstract][Full Text] [Related]
7. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy. Zhang G; Liu F; Jia E; Jia L; Zhang Y Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422 [TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system. Zhang S; Lu C; Zhang X; Li J; Jiang H Drug Deliv; 2016 Jun; 23(5):1838-45. PubMed ID: 26879035 [TBL] [Abstract][Full Text] [Related]
9. Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood-brain-barrier and glioblastoma stem cells. Zhao C; Zhu X; Yang H; Tan J; Gong R; Mei C; Cai X; Su Z; Kong F Biomed Mater; 2024 Aug; 19(5):. PubMed ID: 39134023 [TBL] [Abstract][Full Text] [Related]
10. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy. Wang Y; Wang S; Shi P Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation. Yue Y; Zhao D; Yin Q Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of folate-mediated PEGylated nanostructured lipid carriers for the efficient delivery of furanodiene. Zhang J; He Y; Jiang J; Li M; Jin C; Wang L; Wang D Drug Dev Ind Pharm; 2017 Oct; 43(10):1610-1618. PubMed ID: 28481661 [TBL] [Abstract][Full Text] [Related]
14. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery. Zhang B; Zhang Y; Yu D Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442 [TBL] [Abstract][Full Text] [Related]
15. Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect. Xu M; Li G; Zhang H; Chen X; Li Y; Yao Q; Xie M Drug Deliv; 2020 Dec; 27(1):983-995. PubMed ID: 32611218 [TBL] [Abstract][Full Text] [Related]
16. Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma. Fourniols T; Randolph LD; Staub A; Vanvarenberg K; Leprince JG; Préat V; des Rieux A; Danhier F J Control Release; 2015 Jul; 210():95-104. PubMed ID: 25982679 [TBL] [Abstract][Full Text] [Related]
17. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation. Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells. Hu J; Wang J; Wang G; Yao Z; Dang X Int J Mol Med; 2016 Mar; 37(3):690-702. PubMed ID: 26782731 [TBL] [Abstract][Full Text] [Related]
19. Liposomal temozolomide drug delivery using convection enhanced delivery. Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727 [TBL] [Abstract][Full Text] [Related]
20. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma. Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]